New York, NY (PRWEB) November 12, 2013
Kantar Health, a leading global healthcare consulting firm, will release new details on biosimilar opportunities and challenges for pharmaceutical manufacturers in Asia at the EphMRA 2013 Asia Conference on November 14 in Singapore. Questa Lin, General Manager, Taiwan, and Simon Li, General Manager, China, will present.
In their presentation, “Uncover Biosimilars Opportunities and Challenges – Utilising Market Insights,” Ms. Lin and Mr. Li will provide a comprehensive understanding of the opportunities and barriers for developing biosimilars, how to apply market access strategies, and the research required to produce forecasting estimates.
In addition, Alice Lee, Regional Talent Director at Kantar Health, will participate in the panel discussion “Talent Management Issues” on November 13, which will focus on challenges in recruiting and retaining market researchers.
Kantar Health is a Silver Sponsor of the EphMRA 2013 Asia Conference. More information on this event can be found at http://www.ephmra.org/events/2013-asia-conference.aspx.
About Kantar Health
Kantar Health is a leading global healthcare consulting firm and trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.
Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the
Copyright©2012 Vocus, Inc.
All rights reserved